[Testicular tumors: our follow-up and treatment protocol. Report of 30 cases]

The high incidence of testicular tumors seen in our setting prompted us to review our therapeutic and follow-up protocols and assess patient survival and course within the period spanning June, 1989 to August, 1992. During this 38-month period, we diagnosed a total of 30 cases (15 seminoma, 2 pure embryonal carcinoma, 8 mixed embryonal, 3 lymphoma and 2 Leydig cell tumors). Apart from orchidectomy, we utilized radiotherapy, chemotherapy and resection of residual tumor mass, according to the histological type and tumor stage. Of the 15 seminomas, there was 1 death (6%), 9 cases (60%) are tumor free with a mean survival of 25 months, and 5 cases (34%) are in partial remission at 11.3 months mean follow-up. Of the 10 nonseminomatous tumors, there was 1 death (10%), 5 patients (50%) are in complete remission at 23.6 months (mean), 3 (30%) are in partial remission at 19.3 months (mean) and 1 (10%) is in frank progression as manifested by the unresectable masses of the retroperitoneal lymph nodes. The survival rate for the seminoma group was 94% and 90% for the nonseminomatous tumors.